Zimmer Biomet (ZBH) appointed Mr. Ivan Tornos as Group President, Orthopedics, effective November 1, 2018. He will lead ZBH’s large joint reconstruction, sports medicine, extremities and trauma businesses, as well as the company’s Americas region.
Mr. Tornos has served for more than two decades in various global roles for Fortune 50 to 500 companies. He was most recently the Worldwide President for Urology/Medical and Critical Care at Becton Dickinson, and also held executive leadership positions with C.R. Bard, Covidien International, Baxter International and Johnson and Johnson.
Mr. Tornos holds an MBA from the University of Miami School of Business and a BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business. He is also a 2015 graduate of the Harvard Business School, having completed the Advanced Management Program (AMP 187), in addition to completing Leadership and Management programs at the Cox School of Business of Southern Methodist University. He finalized post-MBA work at the Wharton School of the University of Pennsylvania (CPD Marketing/Finance).
Source: Zimmer Biomet
More leadership news:
NuVasive names J. Christopher Barry to succeed Gregory T. Lucier as Chief Executive Officer
Smith & Nephew debuts new commercial model, creates global franchises with new presidents
Zimmer Biomet (ZBH) appointed Mr. Ivan Tornos as Group President, Orthopedics, effective November 1, 2018. He will lead ZBH’s large joint reconstruction, sports medicine, extremities and trauma businesses, as well as the company’s Americas region.
Mr. Tornos has served for more than two decades in various global roles for Fortune 50 to 500...
Zimmer Biomet (ZBH) appointed Mr. Ivan Tornos as Group President, Orthopedics, effective November 1, 2018. He will lead ZBH’s large joint reconstruction, sports medicine, extremities and trauma businesses, as well as the company’s Americas region.
Mr. Tornos has served for more than two decades in various global roles for Fortune 50 to 500 companies. He was most recently the Worldwide President for Urology/Medical and Critical Care at Becton Dickinson, and also held executive leadership positions with C.R. Bard, Covidien International, Baxter International and Johnson and Johnson.
Mr. Tornos holds an MBA from the University of Miami School of Business and a BBA in Finance and International Marketing and Management from the University of Georgia Terry College of Business. He is also a 2015 graduate of the Harvard Business School, having completed the Advanced Management Program (AMP 187), in addition to completing Leadership and Management programs at the Cox School of Business of Southern Methodist University. He finalized post-MBA work at the Wharton School of the University of Pennsylvania (CPD Marketing/Finance).
Source: Zimmer Biomet
More leadership news:
NuVasive names J. Christopher Barry to succeed Gregory T. Lucier as Chief Executive Officer
Smith & Nephew debuts new commercial model, creates global franchises with new presidents
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
ME
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.